Randomized trial: Early interdisciplinary supportive care in patients with previously untreated metastatic esophagogastric cancer
12 Jan, 2021 | 01:36h | UTC
Commentaries on Twitter
RCT of early interdisciplinary supportive care (ESC) in metastatic esophagogastric cancer
ESC by oncologists, dietitians & psychologists
⬆️ chemo cycles from 4 to 5
⬆️ OS HR=0.68
➡️ PFS
↗️ QoL
To be considered in radiochemotherapy #radonchttps://t.co/G6WQS8ULCb— Matthias Guckenberger (@Mat_Guc) January 10, 2021
Impressive survival benefit for early integrated multidisciplinary nutritional and psychological support vs. standard of care in Phase III trial for metastatic esophagogastric cancers in @ASCO_pubs. Intervention 14.8 mo vs. SOC 11.9 mo. https://t.co/FWE6xlPH8v
— Michael Shusterman, MD (@guildsman) January 9, 2021